Literature DB >> 7819538

Low dopamine transporter mRNA levels in midbrain regions containing calbindin.

M K Sanghera1, K F Manaye, C L Liang, A M Lacopino, M J Bannon, D C German.   

Abstract

The dopamine transporter (DAT) is the site at which the neurotoxic metabolite of MPTP gains access to midbrain dopaminergic (DA) neurons. However, not all midbrain DA neurons degenerate following MPTP treatment. The midbrain DA neurons that contain the calcium-binding protein, calbindin-D28k (CALB), are relatively invulnerable to MPTP toxicity, compared with DA neurons that lack CALB. Using in situ hybridization and immunocytochemical staining techniques in the rat and mouse, we now report that there is as much as 10 fold less DAT mRNA in regions where DA neurons contain CALB compared with regions where DA neurons lack CALB. These data suggest that specific midbrain DA neurons are invulnerable to MPTP toxicity not only because they contain CALB, but also because they have relatively low DAT activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819538     DOI: 10.1097/00001756-199408150-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  Dopamine release and uptake dynamics within nonhuman primate striatum in vitro.

Authors:  S J Cragg; C J Hille; S A Greenfield
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 3.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

4.  Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease.

Authors:  R K Schwarting; M Sedelis; K Hofele; G W Auburger; J P Huston
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

5.  Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine.

Authors:  Stephanie J Cragg; Christopher J Hille; Susan A Greenfield
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 6.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

7.  Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor.

Authors:  C Pellicano; F R Buttarelli; A Circella; D Tiple; M Giovannelli; D Benincasa; C Colosimo; F E Pontieri
Journal:  J Neural Transm (Vienna)       Date:  2007-01-29       Impact factor: 3.850

Review 8.  Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.

Authors:  Giorgio Rizzi; Kelly R Tan
Journal:  Front Neural Circuits       Date:  2017-12-22       Impact factor: 3.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.